Drug-susceptibility tests on *Brachyspira hyodysenteriae* using an agar dilution technique have been reported by Kitai *et al.* \[[@r4]\], and the results have been applied for the eradication of *B. hyodysenteriae* from pig herds affected with swine dysentery. Formerly, carbadox and lincomycin had frequently been used, and recently, valnemulin and tiamulin are using for prevention and eradication of swine dysentery. The MICs of carbadox ranged from 0.003\> to 0.05 and lincomycin ranged from 25 to 100 \[[@r12]\]. Concurrently, drug-resistant *B. hyodysenteriae*, and *B. pilosicoli* have also been reported \[[@r6], [@r10]\]. In this study, we performed drug-susceptibility tests to investigate the MICs and the presence of drug-resistant isolates of *B. hyodysenteriae* isolated from colonic mucosal specimens collected from slaughter houses in 2009. Several *Brachyspira* species have been isolated from pigs in slaughter houses in the U.S.A. \[[@r2]\], as has *B. hyodysenteriae* in Japan. In order to obtain relevant minimum inhibitory concentration (MIC) values, the classification of brachyspiral isolates can be important. If the isolates were not classified as *B.hyodysenteriae*, several species differing from *B.hyodysenteriae* may be contaminated and in drug-susceptibility tests, the MIC values may be different from the values in the tests using classified isolates. Therefore, we performed drug-susceptibility tests using classified isolates.

The brachyspiral isolation from colonic specimens was performed as follows: Sheep blood trypticase soy agar (TSA, Difco, Detroit, MI, U.S.A.) containing 400 *µ*g/m*l* spectinomycin (Pfizer, Tokyo, Japan) was used for the anaerobic isolation as described previously \[[@r11]\] using AnaeroPak Kenki (Mitsubishi Gas Chem., Tokyo, Japan). Isolates were subcultured three times, and the pure isolates were identified as follows: PCR with NOX1 primers using template DNA extracted from the isolates using Instagene^TM^ Matrix (BIO-RAD, Hercules, CA, U.S.A.) was performed \[[@r1]\]. In addition, the 16S rDNA gene was sequenced after PCR using F3 and R500 primers \[[@r3], [@r8], [@r9]\], and the base alignments were compared with those of representative strains obtained from DDBJ. An indole production test was carried out as described previously \[[@r8]\]. Thereafter, the isolates classified as *B. hyodysenteriae* were used for drug-susceptibility tests against 13 antimicrobial agents: carbadox (Pfizer), tiamulin (Novartis Animal Health, Tokyo, Japan), lincomycin (Pharmacia Upjohn, Yokohama, Japan), penicillin G (Meiji Seika Co., Tokyo, Japan), ampicillin (Wako, Osaka, Japan), chloramphenicol (Wako), tetracycline (Wako), erythromycin (Dainippon Pharmaceutical, Osaka, Japan), tylosin (Pfizer), tylvalosin (Bayer, Osaka, Japan), metronidazole (Wako), enrofloxacin (Bayer) and valnemulin (Novartis Animal Health). Drug-susceptibility tests were carried out by an agar dilution technique as described previously \[[@r4]\]. All drugs except for carbadox were diluted by two-fold dilution from 1,000 to 1 *µ*g/m*l*, and 1 m*l* of the diluted drugs was mixed with 9 m*l* of 4% sheep blood agar. After fixing, the blood agar was used for drug-susceptibility tests. Carbadox was diluted by two-fold dilution from 1,000 to 0.013 *µ*g/m*l*, and blood agars containing carbadox were prepared as mentioned above.

For isolation and identification of *B. hyodysenteriae*, colonic mucosal specimens of approximately 5 cm^2^ from 100 pigs were collected from slaughter houses in Ibaraki Prefecture, Japan, in 2009 and kept at −80°C. The isolation was performed in 2010 as follows: small mucosal specimens of 2 mm^2^ from three different regions from each large specimen were cut out, suspended in trypticase soy broth (BBL, U.S.A.) and shaken vigorously. A 25 *µl* aliquot of the suspension was inoculated and grown anaerobically. The isolation was qualitative and suitable for the isolation from colonic mucosa without limiting dilution technique, and the growth of *B.hyodysenteriae* was not disturbed by other motile bacteria, i.e. *Proteus* sp. and, *Salmonella* sp.. Twenty-nine isolates were identified, and the characteristics were as follows: positive PCR with NOX1 primers, homology greater than 99.7% with the 16S rDNA sequence of representative *B. hyodysenteriae*, β-hemolysis on blood agar and positive indole production. The base alignments of the 16S rDNA of *B. hyodysenteriae* isolates from F3 to R500 were registered in DDBJ (Accession No.LC055432-055461).

For the drug-susceptibility tests, classified *B. hyodysenteriae* were used, and the results are shown in [Tables 1](#tbl_001){ref-type="table"}Table1.Drug-susceptibility of 29 isolates of *Brachyspira hyodysenteriae*Antimicrobial agentMIC (*µg*/*ml*)*B. hyodysenteriae*RangeMIC~90~^a)^MIC~50~^b)^Carbadox0.013\>--0.050.013\>0.013\>Tiamulin0.1--12.56.251.56Lincomycin0.78--2512.53.13Penicillin G0.39--6.251.560.39Ampicillin0.1\>--6.256.250.39Chloramphenicol1.56--3.133.131.56Tetracycline0.1\>--6.256.250.39Erythromycin50--100\<100\<100\<Tylosin0.1\>--100\<100\<100Tylvalosin0.39--1005025Metronidazole0.1\>--0.390.390.2Enrofloxacin0.1\>--50253.13Valnemulin0.39--6.256.253.13a) MICs of 90%≤ of the isolates used in these tests. b) MICs of 50%≤ of the isolates used in these tests. and [2](#tbl_002){ref-type="table"}Table 2.Distribution of each MIC of *B.hyodysenteriae* isolates depending on drug concentrationAntimicrobial agentsDistribution of each MIC (*µ*g/m*l*)0.1\>0.10.20.390.781.563.136.2512.52550100100\<Carbadox29^a)^000000000000Tiamulin000111111410000Lincomycin20007333101000Penicillin G00312670100000Ampicillin50311122500000Chloramphenicol00000252200000Tetracycline7009711400000Erythromycin00000000023321Tylosin00000000144155Tylvalosin0001026239510Metronidazole60158000000000Enrofloxacin 77001106813200Valnemulin101214101000000a) Range of carbadox was 0.013\>--0.05.. The twenty-nine *B. hyodysenteriae* isolates were most susceptible to carbadox and metronidazole, whereas macrolides, i.e., erythromycin, tylosin and tylvalosin, had no effect on these isolates. Unfortunately, the use of carbadox had been legally prohibited from medicating and preventing pigs, because carbadox is a carcinogenic substance. The isolates showed intermediate susceptibility to tiamulin, lincomycin, penicillin G, ampicillin, chloramphenicol, tetracycline and valnemulin. The MIC~90~ values ranged from 1.56 to 12.5. These results using classified isolates may indicate relevant MIC values, and they were similar to the results reported by Uezato *et al.* \[[@r12]\], but there were several differences, with comparatively higher MICs for tiamulin, and valnemulin than the previous results \[[@r12]\]. After continuous drug-administration for eradication of swine dysentery, the isolates may have acquired drug-resistance. *B.hyodysenteriae* ATCC 31212 \[[@r7]\] has acquired the resistance to tylosin \[[@r5], [@r6]\] and erythromycin \[[@r6]\]. The point mutation at base position 2058 of 23S rDNA was observed \[[@r6]\] and was A-T transition mutation \[[@r6]\], whereas strain ATCC27164 was sensitive to tylosin \[[@r5]\], and the MICs were 1.56--12.5 to the drug \[[@r5]\] and any point mutation at base position 2058 was not observed \[[@r6], [@r10]\]. Therefore, in the case of macrolides, point mutations in the 23S rDNA of *B. hyodysenteriae* play a role in drug resistance and need to be investigated to determine of the mechanism.
